医学
膨胀
肠易激综合征
动物双歧杆菌
内科学
便秘
临床终点
胃肠病学
益生菌
随机对照试验
生活质量(医疗保健)
人口
排便
初级保健
双歧杆菌
腹泻
乳酸菌
食品科学
发酵
家庭医学
细菌
化学
护理部
环境卫生
生物
遗传学
作者
Denis Guyonnet,Olivier Chassany,Philippe R. Ducrotte,C. PICARD,Michel Mouret,C.‐H. MERCIER,Claude Matuchansky
标识
DOI:10.1111/j.1365-2036.2007.03362.x
摘要
BACKGROUND: Health-related quality of life (HRQoL) has been rarely evaluated as a primary endpoint in the assessment of the effect of probiotics on the irritable bowel syndrome (IBS). AIM: To study the effects of fermented milk containing Bifidobacterium animalis DN-173 010 and yoghurt strains on the IBS in a multicentre, double-blind, controlled trial. METHODS: A total of 274 primary care adults with constipation-predominant IBS (Rome II) were randomized to consume for 6 weeks either the test fermented milk or a heat-treated yoghurt (control). HRQoL and digestive symptoms were assessed after 3 and 6 weeks on an intention-to-treat population of 267 subjects. RESULTS: The HRQoL discomfort score, the primary endpoint, improved (P < 0.001) in both groups at weeks 3 and 6. The responder rate for the HRQoL discomfort score was higher (65.2 vs. 47.7%, P < 0.005), as was the decrease in bloating score [0.56 +/- (s.d.)1.01 vs. 0.31 +/- 0.87, P = 0.03], at week 3 in the test vs. the control group. In those subjects with <3 stools/week, stool frequency increased (P < 0.001) over 6 weeks in the test vs. control group. CONCLUSIONS: This study suggests a beneficial effect of a probiotic food on discomfort HRQoL score and bloating in constipation-predominant IBS, and on stool frequency in subjects with <3 stools/week.
科研通智能强力驱动
Strongly Powered by AbleSci AI